Marta Lopez-Querol
Overview
Explore the profile of Marta Lopez-Querol including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peeri N, Bertrand K, Na R, De Vivo I, Setiawan V, Seshan V, et al.
J Natl Cancer Inst
. 2024 Sep;
117(1):76-88.
PMID: 39235934
Background: The American Cancer Society recommends physicians inform average-risk women about endometrial cancer risk on reaching menopause, but new diagnoses are rising fastest in women aged younger than 50 years....
2.
Lopez-Codony V, de Andres-Pablo A, Ferrando-Diez A, Fernandez-Montoli M, Lopez-Querol M, Tous S, et al.
PLoS One
. 2024 May;
19(5):e0304080.
PMID: 38768231
Human Papillomavirus (HPV) prophylactic vaccination has proven effective in preventing new infections, but it does not treat existing HPV infections or associated diseases. Hence, there is still an important reservoir...
3.
Penalver-Pinol A, Benavente Y, Frias-Gomez J, Alguacil J, Santibanez M, Contreras-Llanes M, et al.
Environ Health
. 2023 Nov;
22(1):77.
PMID: 37919733
Background: Endometrial cancer is the most common gynaecological tumour in developed countries and disease burden is expected to increase over the years. Identifying modifiable risk factors may help developing strategies...
4.
Pelegrina B, Paytubi S, Marin F, Martinez J, Carmona A, Frias-Gomez J, et al.
EBioMedicine
. 2023 Jul;
94:104716.
PMID: 37480623
Background: The incidence of endometrial cancer is increasing worldwide. While delays in diagnosis reduce survival, case molecular misclassification might be associated with under- and over-treatment. The objective of this study...
5.
Costas L, Onieva I, Pelegrina B, Marin F, Carmona A, Lopez-Querol M, et al.
Clin Cancer Res
. 2023 Jul;
29(18):3681-3690.
PMID: 37439797
Purpose: Current diagnostic methods for endometrial cancer lack specificity, leading to many women undergoing invasive procedures. The aim of this study was to evaluate somatic mutations in urine to accurately...
6.
Torres E, Duque M, Lopez-Querol M, Taylor M, Naesens L, Ma C, et al.
Bioorg Med Chem
. 2011 Dec;
20(2):942-8.
PMID: 22178660
The synthesis of several 6,7,8,9,10,11-hexahydro-9-methyl-5,7:9,11-dimethano-5H-benzocyclononen-7-amines is reported. Several of them display low micromolar NMDA receptor antagonist and/or trypanocidal activities. Two compounds are endowed with micromolar anti vesicular stomatitis virus activity,...
7.
Duque M, Camps P, Torres E, Valverde E, Sureda F, Lopez-Querol M, et al.
Bioorg Med Chem
. 2009 Dec;
18(1):46-57.
PMID: 19954985
The synthesis of several (1,2,3,5,6,7-hexahydro-1,5:3,7-dimethano-4-benzoxonin-3-yl)amines and related compounds is reported. Several of them display very similar activity to memantine as NMDA receptor antagonists. Several derivatives showed a significant level of...
8.
Folch J, Alvira D, Lopez-Querol M, Tajes M, Sureda F, Forsby A, et al.
Toxicol In Vitro
. 2009 Oct;
24(2):465-71.
PMID: 19815060
Caspase-3 is a key protein involved in the classical apoptosis mechanism in neurons, as in many other cells types. In the present research, we describe the transcriptional activity of caspase-3...
9.
Duque M, Camps P, Profire L, Montaner S, Vazquez S, Sureda F, et al.
Bioorg Med Chem
. 2009 Mar;
17(8):3198-206.
PMID: 19251424
The synthesis of several (2-oxaadamant-1-yl)amines is reported. They were evaluated as NMDA receptor antagonists and several of them were more active than amantadine, but none was more potent than memantine....
10.
Camps P, Duque M, Vazquez S, Naesens L, De Clercq E, Sureda F, et al.
Bioorg Med Chem
. 2008 Oct;
16(23):9925-36.
PMID: 18954995
The synthesis of several (3-noradamantyl)amines, [(3-noradamantyl)methyl]amines, (3,7-dimethyl-1-bisnoradamantyl)amines, and [(3,7-dimethyl-1-bisnoradamantyl)methyl]amines is reported. They were evaluated against a wide range of viruses and one of them inhibited the cytopathicity of influenza A...